Hepatology International,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 16, 2024
Abstract
Background
The
international
consensus
to
revise
non-alcoholic
fatty
liver
disease
metabolic
(dysfunction)-associated
(MAFLD)
in
2020
attracted
significant
attention.
impact
of
the
MAFLD
definition
on
research
community
has
not
been
objectively
assessed.
We
conducted
an
analysis
systematically
collected
literature
understand
its
impact.
Methods
From
PubMed,
Web
Science,
and
Scopus,
adopting
MAFLD,
written
English,
published
from
10
October
2023
was
collected.
publication
metrics,
including
counts,
publishing
journals,
author
countries,
keywords,
citation
information,
were
analyzed
evaluate
key
topics
MAFLD.
Results
1469
MAFLD-related
papers
434
journals
with
a
steady
increase
number.
intense
citations
activity
indicates
large
redefinition.
Topic
assessment
keyword
revealed
transition
proposal
discussion
redefinition
clinical
characterization
focus
dysfunction.
Moreover,
diagnostic
criteria
for
showed
better
performance
predicting
hepatic
extrahepatic
outcomes
compared
NAFLD.
publications
99
countries
evidence
strong
regional
global
collaboration.
Multiple
societies
stakeholders
have
endorsed
utility
practice,
improving
patient
management
promoting
multidisciplinary
care,
while
alleviating
stigma.
Conclusion
This
survey
provides
quantitative
measure
considerable
contributions
towards
as
part
spectrum
cardiometabolic
disorders.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 2, 2025
This
study
investigated
the
association
between
NAFLD
and
liver
fibrosis
ratio
of
gamma-glutamyl
transferase
to
high-density
lipoprotein
cholesterol
(GGT/HDL-C).
In
this
cross-sectional
study,
we
included
4764
subjects
who
participated
in
National
Health
Nutrition
Examination
Survey
(NHANES)
during
2017–2018.
Adjusted
multivariate
logistic
regression
analysis
was
utilized
evaluate
relationships
GGT/HDL-C
levels
NAFLD,
fatty
degree,
fibrosis.
The
non-linear
link
examined
using
generalized
additive
models.
There
a
risk
all
models
demonstrated
strong
relationship
fibrosis,
degree
hepatic
steatosis,
prevalence
NAFLD.
Subgroup
analyses
revealed
significant
correlation
among
Mexican
Americans
young
people
20–40
age
range.
receiver
operating
characteristic
(ROC)
showed
that
more
accurate
predictor
than
GGT
or
HDL-C
alone.
U.S.
population,
an
increased
severity
are
independently
correlated
with
elevated
ratio.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
To
explore
the
current
research
status
and
trends
of
potassium-competitive
acid
blockers
(P-CABs)
in
treatment
related
diseases
(ARDs)
using
bibliometric
analysis.
We
collected
publications
to
P-CAB
acid-related
Web
Science
(WOS)
Core
Collection
from
establishment
database
30
June
2024.
evaluated
publication
volume
citation
over
years
WOS
platform,
visualized
authors,
countries,
institutions,
keywords,
citations
CiteSpace
VOSviewer.
This
study
included
a
total
455
articles.
The
number
has
been
increasing
year
by
year.
results
show
that
scholars
with
highest
mainly
come
South
Korea
Japan.
Scholars
such
as
Geun
Seog
Song,
Bongtae
Kim,
Nobuhiro
Inatomi
produced
many
works
fields.
most
popular
drug
this
field
was
vonoprazan,
on
focused
effectiveness
safety
evaluation
ARDs
Helicobacter
pylori
infection,
gastroesophageal
reflux
disease,
peptic
ulcers,
etc.
Researchers
were
concerned
about
regimens
efficacy
comparison
between
P-CABs
traditional
proton
pump
inhibitors
(PPIs)
ARDs.
At
same
time,
researchers
are
also
closely
monitoring
potential
adverse
reactions
long-term
outcomes
clinical
application
for
P-CABs,
represented
is
receiving
widespread
attention
researchers.
exploration
type
constantly
expanding,
it
great
value
potential.
Saudi Journal of Gastroenterology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
Abstract
Background:
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
presents
a
significant
global
health
challenge,
with
the
Arab
region
exhibiting
markedly
higher
prevalence.
We
aim
to
evaluate
MASLD
research
output,
collaboration
patterns,
and
funding
impact
in
over
last
decade.
Methods:
conducted
bibliometric
analysis
of
22
countries
(2014–2023)
using
Clarivate
Analytics’
InCites.
Data
on
prevalence
were
extracted
from
Global
Burden
Disease,
while
population
economic
data
World
Bank.
assessed
MASLD-related
publications,
prevalence,
citation
impact.
Results:
Between
2014
2023,
contributed
844
publications
(3.3%
research).
identified
positive
correlations
between
gross
domestic
product
(GDP)
(
r
s
=
0.825,
P
<
0.001),
age-standardized
0.627,
0.002),
size
0.509,
0.016).
International
collaborations
accounted
for
48.7%
these
15.7
compared
average
23.7.
Arab-funded
constituted
19.4%
world
versus
42.3%
globally
funded.
Citation
impacts
similar
(30.6)
funded
(30.3).
Of
top
10
highest
GDP,
47.8%
received
funding,
yielding
33.5.
Conclusion:
Despite
high
exhibit
lower
impact,
levels.
Increased
regional
investment
are
critical
addressing
this
disparity.
Phytotherapy Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 4, 2025
It
is
widely
recognized
that
there
currently
no
established
treatment
for
individuals
with
Non-alcoholic
Fatty
Liver
Disease
(NAFLD).
In
recent
years,
has
been
a
surge
of
interest
in
natural
products
derived
from
plants,
driven
by
their
minimal
toxicity
and
notable
efficacy.
was
reported
could
ameliorate
NAFLD
via
various
mechanisms.
On
the
other
hand,
autophagy
suggested
to
be
involved
pathogenesis
NAFLD.
The
aim
this
review
understand
whether
beneficial
effects
on
are
mediated
affecting
pathways.
review,
we
have
compiled
data
elucidating
how
these
exhibit
potential
improve
modulating
core
autophagic
Specifically,
demonstrate
products,
including
resveratrol,
berberine,
curcumin,
quercetin,
punicalagin,
epigallocatechin-3-gallate,
apigenin,
many
others,
regulate
through
key
signaling
pathways,
such
as
AMPK/SIRT1/mTOR.
Interestingly,
compounds
might
activate
or
inhibit
autophagy,
depending
context.
We
explore
activation
promotes
degradation
lipid
droplets
alleviates
liver
injury,
while
inhibition
contributes
reducing
inflammation,
apoptosis,
pyroptosis,
also
resulting
improved
outcomes.
Taken
together,
findings
suggest
targeting
presents
promising
mechanism
preventing
treating
Frontiers in Pediatrics,
Journal Year:
2025,
Volume and Issue:
13
Published: April 28, 2025
Background
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD),
once
known
as
Non-alcoholic
fatty
disease,
impacts
between
3%
and
10%
of
children
adolescents
globally,
well
nearly
one-third
obsessed
boys
one-quarter
girls,
is
the
most
frequent
cause
pediatric
associated
with
obesity
epidemic.
With
growing
attention
increasing
volume
literature
on
MASLD,
there
an
urgent
need
for
bibliometric
analysis
visualization
in
area
MASLD
study
terms
dissecting
priorities.
Methods
Literature
was
searched
Web
Science
Core
Collection
database,
followed
by
categorization,
visual
conducted
applying
software
including
Citespace,
VOSviewer,
R
language.
The
concentrated
analyzing
information
related
to
key
authors,
spatial
temporal
distribution,
core
keywords,
important
citations.
Results
In
total,
3,409
publications
were
collected
study,
2,697
articles
712
review
articles.
Between
2004
2024,
had
been
constantly
per
year.
country
numerous
United
States,
which
extensive
exchanges
collaborations
Italy,
China,
England,
Italy.
Journal
Pediatric
Gastroenterology
Nutrition
greatest
quantity
this
domain.
a
clinical
guideline.
Insulin
resistance,
metabolic
syndrome,
steatohepatitis,
hepatocellular
carcinoma,
cardiovascular
risk,
diabetes
diagnostic
accuracy,
lifestyle
intervention,
gut
microbiome,
probiotics,
also
hot
topics
frontier
trends
studies.
Conclusion
This
research
represents
inaugural
application
examine
developmental
trajectory
studies
over
past
two
decades,
reveals
that
etiology,
pathological
changes
liver,
relationship
obesity,
complications,
comorbidities,
diagnosis
treatments
are
focuses
provides
academic
references
clinicians
scholars
grasp
hotspots,
cutting
edge
evolving
area.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4256 - 4256
Published: April 30, 2025
Metabolic-dysfunction-associated
steatotic
liver
disease
(MASLD)
has
emerged
as
a
significant
public
health
concern,
attributed
to
its
increasing
prevalence
and
correlation
with
metabolic
disorders,
including
obesity
type
2
diabetes.
Recent
research
highlighted
that
mitochondrial
dysfunction
can
result
in
the
accumulation
of
lipids
non-adipose
tissues,
well
increased
oxidative
stress
inflammation.
These
factors
are
crucial
advancing
progression
MASLD.
Despite
advances
understanding
MASLD
pathophysiology,
challenges
remain
identifying
effective
therapeutic
strategies
targeting
dysfunction.
This
review
aims
consolidate
current
knowledge
on
how
imbalance
affects
development
MASLD,
while
addressing
existing
gaps
potential
avenues
for
future
research.
was
conducted
after
systematic
search
comprehensive
academic
databases
such
PubMed,
Embase,
Web
Science
gather
information
mitochondrial-based
treatments
Gut Pathogens,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: July 3, 2024
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
increasingly
recognized
as
a
significant
health
issue.
Emerging
research
has
focused
on
the
role
of
gut
microbiota
in
NAFLD,
emphasizing
gut-liver
axis.
This
study
aimed
to
identify
key
trends
and
guide
future
investigations
this
evolving
area.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 17, 2024
Background
Platycodin
D
(PD)
has
been
reported
to
treat
metabolic
diseases,
including
non-alcoholic
fatty
liver
disease.
In
addition,
platycodin
activate
intestinal
5'AMP-activated
protein
kinase
(AMPK)
phosphorylation
levels,
thereby
reducing
lipid
absorption.
Therefore,
the
aim
of
this
study
is
explore
whether
PD
activation
AMPK
and
reduced
absorption
can
improve
Methods
Clean-grade
male
C57/BL
mice
were
fed
a
high-fat
diet
(HFD)
(containing
60%
calories)
for
16
weeks,
oral
(10
mg/kg/day)
was
administered
at
same
time.
The
intestines
collected,
tested.
expressions
genes
(CD36,
NPC1L1,
ApoB),
serum
total
triglyceride
(TG)
cholesterol
(TC)
levels
in
livers,
fecal
free
acid
(FFA)
expression
phosphorylated
proteins
examined
using
Western
blot
analyses.
distribution
intestines,
fat
detected
Oil
Red
O
hematoxylin
eosin
(H&E)
staining.
A
colon
cancer
cell
line
(Caco2)
used
confirm
effect
on
cellular
uptake
vitro
.
inflammatory
factors
enzymes
measured
clarify
impact
circulation
syndrome.
Leptin-deficient
(OB)
then
further
improvement
body
weight
blood
lipids.
Results
had
very
significant
therapeutic
or
preventive
syndrome
induced
by
diet.
improved
weight,
insulin
sensitivity,
glucose
tolerance
also
prevented
disease,
increased
excretion.
activating
protein,
which
may
have
involved
inhibition
gene
ApoB).
combined
these
hepatic
accumulation
adipose
tissue.
It
found
that
weights
leptin-deficient
mice.
Conclusion
strong
under
diet-induced
obesity
disease
inhibiting